Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Accumulated Expenses (2024 - 2026)

Updated

Kardigan (KARD) reported Accumulated Expenses of $23.97 million for Q3 2026, down 8.4% from the prior quarter.

Analysis

Kardigan (KARD) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Kardigan posted Accumulated Expenses of $23.9 million, up 556.0% from FY2024.

  • By year, Accumulated Expenses came in at $3.64 million in FY2024.
  • Five-year quarterly Accumulated Expenses spans a low of $3.64 million in Q4 2024 and a high of $26.17 million in Q2 2026.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $26.17 million (Q2 2026), $18.85 million (Q1 2026) and $23.9 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kardigan 1.29 Bn -398.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.97 Mn
Jun 30, 2026 26.17 Mn
Mar 31, 2026 18.85 Mn
Dec 31, 2025 23.90 Mn
Dec 31, 2024 3.64 Mn
API Access

Kardigan Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KARD&period=max&api_key=YOUR_API_KEY